Rockwell Medical Stock Price, News & Analysis (NASDAQ:RMTI)

$5.87 +0.20 (+3.53 %)
(As of 02/25/2018 02:16 PM ET)
Previous Close$5.87
Today's Range$5.58 - $5.88
52-Week Range$4.84 - $8.98
Volume212,365 shs
Average Volume228,084 shs
Market Capitalization$303.84 million
P/E RatioN/A
Dividend YieldN/A
Beta2.17

About Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical logoRockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. The Company's drug products include Triferic (ferric pyrophosphate citrate) and Calcitriol (Active Vitamin D) Injection. Triferic is an iron compound that is delivered to hemodialysis patients through dialysate, replacing the iron loss that occurs during their dialysis treatment. Calcitriol (active vitamin D) injection is indicated for treatment of secondary hyperparathyroidism in dialysis patients.

Receive RMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Specialty & Advanced Pharmaceuticals
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:RMTI
CUSIP77437410
Phone248-960-9009

Debt

Debt-to-Equity RatioN/A
Current Ratio8.04%
Quick Ratio6.09%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$53.28 million
Price / Sales5.70
Cash FlowN/A
Price / CashN/A
Book Value$1.03 per share
Price / Book5.70

Profitability

Trailing EPS($0.43)
Net Income$-19,800,000.00
Net Margins-39.28%
Return on Equity-46.63%
Return on Assets-29.36%

Miscellaneous

Employees300
Outstanding Shares51,760,000

Rockwell Medical (NASDAQ:RMTI) Frequently Asked Questions

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

How were Rockwell Medical's earnings last quarter?

Rockwell Medical Inc (NASDAQ:RMTI) issued its quarterly earnings results on Wednesday, November, 8th. The company reported ($0.10) EPS for the quarter, topping the Zacks' consensus estimate of ($0.10) by $0.00. The company had revenue of $14.63 million for the quarter, compared to analysts' expectations of $13.33 million. Rockwell Medical had a negative return on equity of 46.63% and a negative net margin of 39.28%. Rockwell Medical's revenue was up 14.2% on a year-over-year basis. During the same quarter last year, the business earned ($0.09) earnings per share. View Rockwell Medical's Earnings History.

When will Rockwell Medical make its next earnings announcement?

Rockwell Medical is scheduled to release their next quarterly earnings announcement on Tuesday, March, 13th 2018. View Earnings Estimates for Rockwell Medical.

Where is Rockwell Medical's stock going? Where will Rockwell Medical's stock price be in 2018?

1 Wall Street analysts have issued 12 month target prices for Rockwell Medical's shares. Their forecasts range from $11.00 to $11.00. On average, they anticipate Rockwell Medical's share price to reach $11.00 in the next year. View Analyst Ratings for Rockwell Medical.

Who are some of Rockwell Medical's key competitors?

Who are Rockwell Medical's key executives?

Rockwell Medical's management team includes the folowing people:

  • Robert L. Chioini, Chairman of the Board, President, Chief Executive Officer (Age 52)
  • Thomas E. Klema CPA, Chief Financial Officer, Vice President, Treasurer, Secretary (Age 63)
  • Ajay Gupta M.D., Chief Scientific Officer (Age 59)
  • Raymond Dennis Pratt M.D., Chief Medical Officer (Age 66)
  • Patrick J. Bagley, Lead Independent Director (Age 51)
  • John G. Cooper CPA, Director (Age 59)
  • Ronald D. Boyd, Independent Director (Age 54)
  • David T. Domzalski, Independent Director (Age 50)
  • Robin L. Smith M.D., Independent Director (Age 52)

Who owns Rockwell Medical stock?

Rockwell Medical's stock is owned by many different of institutional and retail investors. Top institutional shareholders include RICHMOND BROTHERS, INC. (10.80%), BlackRock Inc. (5.89%), Bank of New York Mellon Corp (0.45%), Deutsche Bank AG (0.23%), Millennium Management LLC (0.07%) and Goldman Sachs Group Inc. (0.05%). Company insiders that own Rockwell Medical stock include David S Richmond and Kenneth L Holt. View Institutional Ownership Trends for Rockwell Medical.

Who sold Rockwell Medical stock? Who is selling Rockwell Medical stock?

Rockwell Medical's stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp. Company insiders that have sold Rockwell Medical company stock in the last year include David S Richmond and Kenneth L Holt. View Insider Buying and Selling for Rockwell Medical.

Who bought Rockwell Medical stock? Who is buying Rockwell Medical stock?

Rockwell Medical's stock was acquired by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Millennium Management LLC, BlackRock Inc., MetLife Investment Advisors LLC and Goldman Sachs Group Inc.. View Insider Buying and Selling for Rockwell Medical.

How do I buy Rockwell Medical stock?

Shares of Rockwell Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rockwell Medical's stock price today?

One share of Rockwell Medical stock can currently be purchased for approximately $5.87.

How big of a company is Rockwell Medical?

Rockwell Medical has a market capitalization of $303.84 million and generates $53.28 million in revenue each year. The company earns $-19,800,000.00 in net income (profit) each year or ($0.43) on an earnings per share basis. Rockwell Medical employs 300 workers across the globe.

How can I contact Rockwell Medical?

Rockwell Medical's mailing address is 30142 S WIXOM RD, WIXOM MI, 48393. The company can be reached via phone at 248-960-9009 or via email at [email protected]


MarketBeat Community Rating for Rockwell Medical (RMTI)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  183 (Vote Outperform)
Underperform Votes:  205 (Vote Underperform)
Total Votes:  388
MarketBeat's community ratings are surveys of what our community members think about Rockwell Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Rockwell Medical (NASDAQ:RMTI) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: Strong BuyStrong BuyStrong BuyBuy
Consensus Rating Score: 4.004.004.002.67
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $11.00$11.00$11.00$9.33
Price Target Upside: 76.28% upside76.28% upside76.28% upside49.57% upside

Rockwell Medical (NASDAQ:RMTI) Consensus Price Target History

Price Target History for Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical (NASDAQ:RMTI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/14/2017Ifs SecuritiesInitiated CoverageStrong-Buy$11.00MediumView Rating Details
11/9/2016BTIG ResearchReiterated RatingBuy$12.00N/AView Rating Details
11/8/2016Bank of AmericaDowngradeNeutral -> Underperform$9.00 -> $5.00N/AView Rating Details
4/6/2016Morgan StanleyReiterated RatingSellN/AView Rating Details
3/1/2016Craig HallumDowngradeBuy -> Hold$7.00N/AView Rating Details
3/1/2016Stifel NicolausDowngradeBuy -> HoldN/AView Rating Details
(Data available from 2/25/2016 forward)

Earnings

Rockwell Medical (NASDAQ:RMTI) Earnings History and Estimates Chart

Earnings by Quarter for Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical (NASDAQ RMTI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/13/2018($0.13)N/AView Earnings Details
11/8/2017Q3 2017($0.10)($0.10)$13.33 million$14.63 millionViewN/AView Earnings Details
8/9/2017Q2 2017($0.10)($0.14)$13.05 million$13.24 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.09)($0.09)$12.66 million$14.60 millionViewListenView Earnings Details
3/15/2017Q4 2016($0.09)($0.10)$15.45 million$13.39 millionViewN/AView Earnings Details
11/7/2016Q3($0.10)($0.09)$15.40 million$12.81 millionViewListenView Earnings Details
8/8/2016Q2($0.10)($0.11)$13.86 million$12.50 millionViewN/AView Earnings Details
5/10/2016Q1($0.08)($0.10)$15.25 million$13.63 millionViewListenView Earnings Details
2/29/2016Q4$0.02($0.12)$19.98 million$14.10 millionViewListenView Earnings Details
11/9/2015Q315($0.02)($0.05)$14.93 million$14.40 millionViewListenView Earnings Details
8/4/2015Q215($0.10)($0.05)$11.84 million$12.96 millionViewListenView Earnings Details
5/7/2015Q414($0.10)($0.07)$13.20 million$13.90 millionViewN/AView Earnings Details
2/26/2015Q4($0.10)($0.14)$13.51 million$14.40 millionViewN/AView Earnings Details
11/10/2014Q314($0.10)($0.10)$13.40 million$13.70 millionViewN/AView Earnings Details
7/31/2014Q2($0.13)($0.08)$13.45 million$13.00 millionViewN/AView Earnings Details
5/12/2014Q1($0.14)($0.20)$14.22 million$13.00 millionViewN/AView Earnings Details
2/26/2014($0.28)($0.21)$14.11 million$13.97 millionViewN/AView Earnings Details
11/5/2013Q3 2013($0.22)($0.34)$13.90 million$13.09 millionViewN/AView Earnings Details
8/1/2013Q2 2013($0.31)($0.38)$13.58 million$12.98 millionViewN/AView Earnings Details
5/8/2013Q1 2013($0.34)($0.72)$13.11 million$12.34 millionViewN/AView Earnings Details
3/18/2013Q4 2012($0.44)($0.66)ViewN/AView Earnings Details
11/8/2012Q312($0.50)($0.86)$12.57 million$12.70 millionViewN/AView Earnings Details
8/7/2012Q2 2012($0.48)($0.58)ViewN/AView Earnings Details
5/3/2012Q1 2012($0.43)($0.54)ViewN/AView Earnings Details
3/1/2012Q4 2011($0.17)($0.49)ViewN/AView Earnings Details
11/3/2011Q3 2011($0.25)($0.28)ViewN/AView Earnings Details
8/4/2011Q2 2011($0.20)($0.26)ViewN/AView Earnings Details
5/5/2011Q1 2011($0.14)($0.17)ViewN/AView Earnings Details
3/3/2011Q4 2010($0.06)($0.10)ViewN/AView Earnings Details
11/4/2010Q3 2010($0.02)($0.04)ViewN/AView Earnings Details
8/5/2010Q2 2010($0.04)$0.01ViewN/AView Earnings Details
5/5/2010Q1 2010($0.06)($0.02)ViewN/AView Earnings Details
3/10/2010Q4 2009($0.06)($0.03)ViewN/AView Earnings Details
11/4/2009Q3 2009($0.11)($0.11)ViewN/AView Earnings Details
8/10/2009Q2 2009($0.12)ViewN/AView Earnings Details
5/11/2009Q1 2009($0.12)ViewN/AView Earnings Details
3/16/2009Q4 2008($0.22)ViewN/AView Earnings Details
11/13/2008Q3 2008($0.18)ViewN/AView Earnings Details
8/12/2008Q2 2008($0.08)ViewN/AView Earnings Details
5/7/2008Q1 2008($0.09)ViewN/AView Earnings Details
3/6/2008Q4 2007($0.01)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Rockwell Medical (NASDAQ:RMTI) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.44 EPS
Next Year EPS Consensus Estimate: $-0.38 EPS

Dividends

Dividend History for Rockwell Medical (NASDAQ:RMTI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Rockwell Medical (NASDAQ RMTI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 15.90%
Institutional Ownership Percentage: 21.16%
Insider Trades by Quarter for Rockwell Medical (NASDAQ:RMTI)
Institutional Ownership by Quarter for Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical (NASDAQ RMTI) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2017David S RichmondInsiderSell36$6.53$235.08176,376View SEC Filing  
3/22/2017David S RichmondInsiderBuy37,210$5.84$217,306.40176,412View SEC Filing  
3/16/2017Kenneth L HoltDirectorSell6,000$5.98$35,880.0017,430View SEC Filing  
11/11/2016Kenneth L HoltDirectorSell19,725$5.16$101,781.0032,355View SEC Filing  
11/1/2016Kenneth L HoltDirectorSell1,400$5.92$8,288.0038,355View SEC Filing  
10/21/2016Kenneth L HoltDirectorSell2,533$6.04$15,299.3241,338View SEC Filing  
9/19/2016Kenneth L HoltDirectorSell8,075$6.81$54,990.7546,858View SEC Filing  
8/25/2016Kenneth L HoltDirectorSell9,520$6.37$60,642.4056,048View SEC Filing  
8/16/2016Kenneth L HoltDirectorSell3,692$7.31$26,988.5263,475View SEC Filing  
12/4/2015Ronald D. BoydDirectorSell12,500$10.58$132,250.0032,500View SEC Filing  
8/14/2015Robert L ChioiniCEOBuy4,910$11.96$58,723.60View SEC Filing  
8/13/2015Raymond Dennis PrattVPBuy5,000$11.54$57,700.00View SEC Filing  
8/13/2015Robert L ChioiniCEOBuy5,090$11.51$58,585.90View SEC Filing  
8/27/2012David A HagelsteinMajor ShareholderBuy7,000$8.10$56,700.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Rockwell Medical (NASDAQ RMTI) News Headlines

Source:
DateHeadline
ValuEngine Lowers Rockwell Medical (RMTI) to Strong SellValuEngine Lowers Rockwell Medical (RMTI) to Strong Sell
www.americanbankingnews.com - February 4 at 3:24 PM
Rockwell Medical Sees Unusually High Options Volume (RMTI)Rockwell Medical Sees Unusually High Options Volume (RMTI)
www.americanbankingnews.com - January 21 at 1:28 AM
Rockwell Medical (RMTI) Stock Rating Upgraded by BidaskClubRockwell Medical (RMTI) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - January 6 at 4:26 PM
Zacks Investment Research Lowers Rockwell Medical (RMTI) to SellZacks Investment Research Lowers Rockwell Medical (RMTI) to Sell
www.americanbankingnews.com - January 4 at 3:38 PM
Rockwell Medical (RMTI) Cut to "Sell" at BidaskClubRockwell Medical (RMTI) Cut to "Sell" at BidaskClub
www.americanbankingnews.com - December 22 at 6:12 PM
Rockwell Medical, Inc. – Value Analysis (NASDAQ:RMTI) : December 18, 2017Rockwell Medical, Inc. – Value Analysis (NASDAQ:RMTI) : December 18, 2017
finance.yahoo.com - December 19 at 5:31 AM
Rockwell Medical (RMTI) Upgraded to Hold at BidaskClubRockwell Medical (RMTI) Upgraded to Hold at BidaskClub
www.americanbankingnews.com - December 16 at 12:02 PM
Rockwell Medical, Inc. breached its 50 day moving average in a Bullish Manner : RMTI-US : December 15, 2017Rockwell Medical, Inc. breached its 50 day moving average in a Bullish Manner : RMTI-US : December 15, 2017
finance.yahoo.com - December 15 at 3:16 PM
Rockwell Medical Technologies (RMTI) Signs Exclusive License ... - StreetInsider.comRockwell Medical Technologies (RMTI) Signs Exclusive License ... - StreetInsider.com
www.streetinsider.com - December 15 at 5:33 AM
Rockwell Medical Technologies (RMTI) Announces Exclusive License Agreement with Quimica Europea to Commercialize Triferic in PeruRockwell Medical Technologies (RMTI) Announces Exclusive License Agreement with Quimica Europea to Commercialize Triferic in Peru
www.streetinsider.com - December 14 at 3:16 PM
Rockwell Medical Signs Exclusive License Agreement with Comercializadora BioRenal SpA to Commercialize Triferic® in ChileRockwell Medical Signs Exclusive License Agreement with Comercializadora BioRenal SpA to Commercialize Triferic® in Chile
finance.yahoo.com - December 14 at 3:16 PM
Rockwell Medical Technologies (RMTI) Announces Exclusive License Agreement with Quimica Europea to ... - StreetInsider.comRockwell Medical Technologies (RMTI) Announces Exclusive License Agreement with Quimica Europea to ... - StreetInsider.com
www.streetinsider.com - December 12 at 3:15 PM
Rockwell Medical Signs Exclusive License Agreement with Quimica Europea to Commercialize Triferic® in PeruRockwell Medical Signs Exclusive License Agreement with Quimica Europea to Commercialize Triferic® in Peru
finance.yahoo.com - December 12 at 3:15 PM
ETFs with exposure to Rockwell Medical, Inc. : December 12, 2017ETFs with exposure to Rockwell Medical, Inc. : December 12, 2017
finance.yahoo.com - December 12 at 3:15 PM
Zacks Investment Research Upgrades Rockwell Medical (RMTI) to "Hold"Zacks Investment Research Upgrades Rockwell Medical (RMTI) to "Hold"
www.americanbankingnews.com - December 1 at 12:28 AM
ETFs with exposure to Rockwell Medical, Inc. : November 27, 2017ETFs with exposure to Rockwell Medical, Inc. : November 27, 2017
finance.yahoo.com - November 27 at 4:22 PM
Smoke And Mirrors At Rockwell Medical? - Seeking AlphaSmoke And Mirrors At Rockwell Medical? - Seeking Alpha
seekingalpha.com - November 26 at 5:52 PM
Rockwell Medical, Inc. (RMTI) Downgraded to "Sell" at Zacks Investment ResearchRockwell Medical, Inc. (RMTI) Downgraded to "Sell" at Zacks Investment Research
www.americanbankingnews.com - November 15 at 6:22 AM
ETFs with exposure to Rockwell Medical, Inc. : November 14, 2017ETFs with exposure to Rockwell Medical, Inc. : November 14, 2017
finance.yahoo.com - November 14 at 3:39 PM
Rockwell Medical, Inc. :RMTI-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017Rockwell Medical, Inc. :RMTI-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017
finance.yahoo.com - November 14 at 7:25 AM
Investors Purchase High Volume of Rockwell Medical Put Options (RMTI)Investors Purchase High Volume of Rockwell Medical Put Options (RMTI)
www.americanbankingnews.com - November 13 at 2:32 AM
Rockwell Medical, Inc. (RMTI) Issues Quarterly  Earnings Results, Hits EstimatesRockwell Medical, Inc. (RMTI) Issues Quarterly Earnings Results, Hits Estimates
www.americanbankingnews.com - November 10 at 4:39 PM
Rockwell Medical Reports Third Quarter Results - GlobeNewswire (press release)Rockwell Medical Reports Third Quarter Results - GlobeNewswire (press release)
globenewswire.com - November 9 at 12:37 PM
Rockwell Medical Reports Third Quarter ResultsRockwell Medical Reports Third Quarter Results
finance.yahoo.com - November 9 at 12:37 PM
Rockwell Medical reports 3Q lossRockwell Medical reports 3Q loss
finance.yahoo.com - November 9 at 12:37 PM
Edited Transcript of RMTI earnings conference call or presentation 8-Nov-17 9:30pm GMTEdited Transcript of RMTI earnings conference call or presentation 8-Nov-17 9:30pm GMT
finance.yahoo.com - November 9 at 12:37 PM
Rockwell Medical Schedules Third Quarter 2017 Earnings Call - GlobeNewswire (press release)Rockwell Medical Schedules Third Quarter 2017 Earnings Call - GlobeNewswire (press release)
globenewswire.com - November 2 at 8:24 AM
Rockwell Medical Schedules Third Quarter 2017 Earnings CallRockwell Medical Schedules Third Quarter 2017 Earnings Call
feeds.benzinga.com - November 1 at 9:28 AM
Rockwell Medical Announces Two Triferic Poster Presentations at American Society of Nephrology Kidney Week 2017 Annual MeetingRockwell Medical Announces Two Triferic Poster Presentations at American Society of Nephrology Kidney Week 2017 Annual Meeting
finance.yahoo.com - October 31 at 8:45 AM
Rockwell Medical, Inc. (RMTI) Set to Announce Earnings on MondayRockwell Medical, Inc. (RMTI) Set to Announce Earnings on Monday
www.americanbankingnews.com - October 30 at 10:43 AM
Rockwell Medical, Inc. (RMTI) Stock Rating Lowered by Zacks Investment ResearchRockwell Medical, Inc. (RMTI) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - October 28 at 6:22 AM
Rockwell Medical, Inc. (RMTI) Receives Average Rating of "Hold" from AnalystsRockwell Medical, Inc. (RMTI) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - October 28 at 2:06 AM
Rockwell Medical Technologies (RMTI) Says FDA Requested Extra Time to Review Calcitriol Post-Approval Drug ... - StreetInsider.comRockwell Medical Technologies (RMTI) Says FDA Requested Extra Time to Review Calcitriol Post-Approval Drug ... - StreetInsider.com
www.streetinsider.com - October 28 at 12:51 AM
Commit To Purchase Rockwell Medical At $5, Earn 21.4% Annualized Using Options - TheStreet.comCommit To Purchase Rockwell Medical At $5, Earn 21.4% Annualized Using Options - TheStreet.com
www.thestreet.com - October 27 at 2:47 PM
Rockwell Medical, Inc. – Value Analysis (NASDAQ:RMTI) : October 25, 2017Rockwell Medical, Inc. – Value Analysis (NASDAQ:RMTI) : October 25, 2017
finance.yahoo.com - October 27 at 2:47 PM
Rockwell Update on Calcitriol Post-Approval Manufacturing Submission to FDA - GlobeNewswire (press release)Rockwell Update on Calcitriol Post-Approval Manufacturing Submission to FDA - GlobeNewswire (press release)
globenewswire.com - October 25 at 9:58 AM
Rockwell Update on Calcitriol Post-Approval Manufacturing Submission to FDARockwell Update on Calcitriol Post-Approval Manufacturing Submission to FDA
finance.yahoo.com - October 25 at 9:58 AM
Rockwell Medical, Inc. breached its 50 day moving average in a Bearish Manner : RMTI-US : October 24, 2017Rockwell Medical, Inc. breached its 50 day moving average in a Bearish Manner : RMTI-US : October 24, 2017
finance.yahoo.com - October 24 at 9:22 AM
ETFs with exposure to Rockwell Medical, Inc. : October 16, 2017ETFs with exposure to Rockwell Medical, Inc. : October 16, 2017
finance.yahoo.com - October 17 at 6:50 AM
Rockwell Medical, Inc. (RMTI) Stock Rating Upgraded by Zacks Investment ResearchRockwell Medical, Inc. (RMTI) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - October 15 at 9:02 PM
ETFs with exposure to Rockwell Medical, Inc. : October 3, 2017ETFs with exposure to Rockwell Medical, Inc. : October 3, 2017
finance.yahoo.com - October 3 at 11:46 AM
Rockwell Medical, Inc. (RMTI) Receives Consensus Rating of "Hold" from AnalystsRockwell Medical, Inc. (RMTI) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - October 3 at 2:44 AM
Rockwell Medical Technologies (RMTI) Says it Filed Calcitriol Post-Approval Manufacturing Submission with FDA - StreetInsider.comRockwell Medical Technologies (RMTI) Says it Filed Calcitriol Post-Approval Manufacturing Submission with FDA - StreetInsider.com
www.streetinsider.com - September 30 at 11:23 PM
Comparing TherapeuticsMD (TXMD) & Rockwell Medical (RMTI)Comparing TherapeuticsMD (TXMD) & Rockwell Medical (RMTI)
www.americanbankingnews.com - September 29 at 12:30 AM
Rockwell Files Calcitriol Post-Approval Manufacturing Submission with FDARockwell Files Calcitriol Post-Approval Manufacturing Submission with FDA
globenewswire.com - September 28 at 8:02 PM
Rockwell Medical Technologies (RMTI) Says it Filed Calcitriol Post-Approval Manufacturing Submission with FDARockwell Medical Technologies (RMTI) Says it Filed Calcitriol Post-Approval Manufacturing Submission with FDA
www.streetinsider.com - September 28 at 8:02 PM
Financial Survey: Rockwell Medical (RMTI) and Its RivalsFinancial Survey: Rockwell Medical (RMTI) and Its Rivals
www.americanbankingnews.com - September 28 at 4:22 PM
Contrasting Rockwell Medical (RMTI) and Aimmune Therapeutics (AIMT)Contrasting Rockwell Medical (RMTI) and Aimmune Therapeutics (AIMT)
www.americanbankingnews.com - September 27 at 2:12 PM
Rockwell Medical, Inc. breached its 50 day moving average in a Bullish Manner : RMTI-US : September 21, 2017Rockwell Medical, Inc. breached its 50 day moving average in a Bullish Manner : RMTI-US : September 21, 2017
finance.yahoo.com - September 22 at 4:56 PM
Rockwell Medical, Inc. :RMTI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017Rockwell Medical, Inc. :RMTI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017
finance.yahoo.com - September 22 at 4:55 PM

SEC Filings

Rockwell Medical (NASDAQ:RMTI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Rockwell Medical (NASDAQ:RMTI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Rockwell Medical (NASDAQ RMTI) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.